Form 4: Crocs EVP Sells Shares Under Pre-Arranged 10b5-1 Plan

Crocs EVP & Crocs Brand President Anne Mehlman sold 12,145 shares of common stock for approximately $1.2 million under a pre-arranged 10b5-1 trading plan.

Summary

• Anne Mehlman, EVP & Crocs Brand President of Crocs, Inc. (CROX), reported a sale of common stock.
• The transaction involved the disposition of 12,145 shares of Crocs common stock.
• The shares were sold at a weighted average price of $100.0553 per share, with prices ranging from $100.0000 to $100.9999.
• The total value of the shares sold is approximately $1,215,170.85.
• Following this transaction, Anne Mehlman beneficially owns 131,112 shares of Crocs common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction conducted under a pre-arranged 10b5-1 plan, which typically does not signal a change in management's outlook on the company's prospects.

Future Outlook

The filing reports a future-dated transaction (February 20, 2026) executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a discretionary one based on immediate market conditions.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are common practice for executives to manage personal finances and diversify holdings without being accused of trading on material non-public information. Such pre-arranged sales are generally viewed as less indicative of management's sentiment about the company's future prospects compared to open market, discretionary sales.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, pre-scheduled insider sale and not indicative of a change in company fundamentals or management's immediate outlook.

Key Dates

Recommendation

This is a routine insider sale under a pre-arranged 10b5-1 plan, which typically does not signal a change in management's outlook on the company's prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Crocs, CROX, Insider Trading, Form 4, Stock Sale, Executive Compensation, 10b5-1 Plan